An artificial intelligence (AI) is better than specialist doctors at diagnosing lung cancer, according to a study from researchers at Google and Northwestern University in Illinois. While not yet ready for clinical use...
Latest articles
AbbVie terminates Phase 3 brain cancer study after Depatux-M shows no benefit
AbbVie has terminated a Phase 3 study of the efficacy of Depatux-M (depatuxizumab mafodotin) in the treatment of newly diagnosed glioblastoma (GBM) in patients whose tumours have epidermal growth factor receptor (EGFR)...
Contentmapping: de koers uitzetten in een zee vol content
Er is online enorm veel content beschikbaar. Bedrijven doen volop mee met de content-wedloop. Maar ze hebben moeite met de content aanpassen aan de gewoontes en behoeftes van hun doelgroep. Is dit iets waar jij je in...
US FDA approves Roche’s Venclexta in combo with Gazyva to treat people with previously untreated CLL/SLL
Roche announced that the US Food and Drug Administration (FDA) has approved Venclexta (venetoclax) in combination with Gazyva (obinutuzumab) for the treatment of people with previously untreated chronic lymphocytic...
US FDA approves Pfizer’s Fragmin to treat paediatric patients with blood clots
The US Food and Drug Administration (FDA) approved Fragmin (dalteparin sodium) injection, for subcutaneous use, to reduce the recurrence of symptomatic venous thromboembolism (VTE) in paediatric
The nine biggest marketing trends of 2019 — and how to stay ahead of them
The post The nine biggest marketing trends of 2019 — and how to stay ahead of them appeared first on Digiday.
